Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReFacto AF (moroctocog alfa) Post-marketing Study in Hemophilia A in China
CTR20150272Phase 4Completed
- Sponsor
- Wyeth
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Wyeth. Started Aug 2015; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20150272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150272.